What is Pluto Bioinformatics?
Pluto Bioinformatics operates as a sophisticated collaborative life sciences platform designed to re-engineer the scientific research lifecycle. By providing a visually intuitive interface, the company enables organizations to manage diverse research programs, monitor critical biomarkers, and ensure secure data sharing across distributed teams. Its market position is defined by its ability to bridge the gap between raw experimental data and actionable scientific insights, serving as a central nervous system for life science enterprises of varying scales.
How much funding has Pluto Bioinformatics raised?
Pluto Bioinformatics has raised a total of $8.3M across 3 funding rounds:
Angel/Seed
$1M
Angel/Seed
$3.7M
Unspecified
$3.6M
Angel/Seed (2021): $1M, investors not publicly disclosed
Angel/Seed (2023): $3.7M led by Silverton Partners
Unspecified (2025): $3.6M supported by Silverton Partners and Kickstarter
Key Investors in Pluto Bioinformatics
Silverton Partners
Silverton Partners is a leading early-stage venture capital firm based in Austin, Texas, specializing in investing in companies that leverage technology to create significant barriers to entry. They manage over $883 million in assets and provide long-term support to bold entrepreneurs.
Kickstarter
Established in 2009, Kickstarter is an online crowdfunding platform and community that enables creators to raise funds for various community projects. They are based in New York.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Pluto Bioinformatics?
With this latest capital infusion, Pluto Bioinformatics is expected to scale its enterprise operations and enhance its platform capabilities to meet the growing complexity of global biotech research. The strategic focus will likely shift toward expanding its footprint in the life sciences sector, potentially integrating advanced analytics and machine learning features to further automate research workflows. As the company transitions into this next phase of growth, the emphasis will remain on maintaining data integrity and fostering collaborative environments that drive scientific innovation forward. The firm is now poised to solidify its status as an essential utility for research-intensive organizations seeking to optimize their R&D pipelines.
See full Pluto Bioinformatics company page
